Literature DB >> 29284293

Assessment of Needle Tip Deflection During Transrectal Guided Prostate Biopsy: Implications for Targeted Biopsies.

Daniel Halstuch1,2, Jack Baniel1,2, David Lifshitz1,2, Sivan Sela1, Yaara Ber1, David Margel1,2.   

Abstract

OBJECTIVES: To measure needle tip deflection during transrectal ultrasound (TRUS) prostate biopsy and evaluate predictors for needle tip deflection.
MATERIALS AND METHODS: Analysis of 568 prostate biopsies obtained from 51 consecutive patients who underwent a standard 12-core TRUS guided prostate biopsy. TRUS guided prostate biopsies were performed using BK flex500, with a side-fire biplane probe. Each biopsy core image was captured and clinical data were recorded prospectively. The angle between the expected trajectory of the needle and actual needle course was measured using the longitudinal view of the captured image. The distance between expected and actual needle tip was calculated. We measured median and interquartile needle tip deflection rate stratified by side and location (apex, midgland, base). Univariable and multivariable linear regressions analysis were performed.
RESULTS: The overall median needle tip deflection was 1.77 mm (IQR 1.35-2.47). Location did not significantly alter needle deflection measurements. On multivariable linear regression analysis, higher prostate volume (B = 0.007 95%, CI 0.004, 0.011; p < 0.001) and the right sided biopsy (B = 0.191 95%, CI 0.047, 0.336; p = 0.010) emerged as predictors of higher needle tip deflection.
CONCLUSIONS: To the best of our knowledge this is the first study to measure needle tip deflection during TRUS guided prostate biopsies. We demonstrated that larger prostate size and biopsy side may affect the accuracy of biopsies. These results may have clinical implication to those performing targeted biopsies.

Entities:  

Keywords:  needle tip deflection; prostate cancer; targeted prostate biopsy; transrectal prostate biopsy

Mesh:

Year:  2018        PMID: 29284293     DOI: 10.1089/end.2017.0694

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

Review 1.  Developing a National Center of Excellence for Prostate Imaging.

Authors:  Annerleim Walton-Diaz; Manuel Madariaga-Venegas; Nicolas Aviles; Juan Carlos Roman; Ivan Gallegos; Mauricio Burotto
Journal:  Curr Urol Rep       Date:  2019-09-02       Impact factor: 3.092

Review 2.  Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?

Authors:  Samuel A Gold; Graham R Hale; Jonathan B Bloom; Clayton P Smith; Kareem N Rayn; Vladimir Valera; Bradford J Wood; Peter L Choyke; Baris Turkbey; Peter A Pinto
Journal:  World J Urol       Date:  2018-05-21       Impact factor: 4.226

3.  Why Does Magnetic Resonance Imaging-Targeted Biopsy Miss Clinically Significant Cancer?

Authors:  Cheyenne Williams; Michael Ahdoot; Michael A Daneshvar; Christian Hague; Andrew R Wilbur; Patrick T Gomella; Joanna Shih; Nabila Khondakar; Nitin Yerram; Sherif Mehralivand; Sandeep Gurram; Minhaj Siddiqui; Paul Pinsky; Howard Parnes; Maria Merino; Bradford Wood; Baris Turkbey; Peter A Pinto
Journal:  J Urol       Date:  2021-08-26       Impact factor: 7.450

4.  Needle deflection and tissue sampling length in needle biopsy.

Authors:  Annie D R Li; Jeffrey Plott; Lei Chen; Jeffrey S Montgomery; Albert Shih
Journal:  J Mech Behav Biomed Mater       Date:  2020-01-11

5.  Multi-Bevel Needle Design Enabling Accurate Insertion in Biopsy for Cancer Diagnosis.

Authors:  Annie D R Li; Yang Liu; Jeffrey Plott; Lei Chen; Jeffrey S Montgomery; Albert Shih
Journal:  IEEE Trans Biomed Eng       Date:  2021-04-22       Impact factor: 4.538

Review 6.  MRI-targeted prostate biopsy: the next step forward!

Authors:  Emanuel Darius Cata; Iulia Andras; Teodora Telecan; Attila Tamas-Szora; Radu-Tudor Coman; Dan-Vasile Stanca; Ioan Coman; Nicolae Crisan
Journal:  Med Pharm Rep       Date:  2021-04-29

7.  Optimizing patient selection for focal therapy-mapping and ablating the index lesion.

Authors:  James S Wysock; Herbert Lepor
Journal:  Transl Androl Urol       Date:  2018-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.